Reaction

Foetal Distress Syndrome reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,093 reports · 52 co-occurring drugs

As of the last recalculation, Foetal Distress Syndrome appears in 2,093 FAERS reports alongside 52 co-occurring drug terms. The strongest observed disproportionality signal is MISOPROSTOL (PRR 90.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Misoprostol	85	90.4	91.2
Zidovudine	71	54.6	54.9
Nevirapine	35	39.2	39.4
Nicotine Polacrilex Mini	54	36.7	36.8
Nicotine Polarilex	54	36.7	36.8
Magnesium Sulfate In Water For	39	30.9	31.0
Magnesium Sulfate Heptahydrate	39	30.3	30.4
Magnesium Sulfate	39	30.3	30.4
Labetalol	31	23.5	23.5
Lopinavir And Ritonavir	27	20.1	20.1
Atazanavir	28	19.6	19.7
Oseltamivir	15	18.9	18.9
Bupivacaine	17	18.2	18.3
Ampicillin	13	15.7	15.7
Ampicillin Sodium	13	15.7	15.7
Nicotine Polacrilex	54	14.4	14.4
Tenofovir Disoproxil Fumarate Tablets	12	13.9	13.9
Nicotine	54	13.6	13.6
Lisdexamfetamine Dimesylate	40	12.3	12.3
Norepinephrine	13	12.2	12.2
Lamivudine	37	12.1	12.1
Ritonavir	34	11.7	11.8
Norepinephrine Bitartrate	15	10.4	10.4
Cefazolin Sodium	12	10.0	10.0
Clarithromycin	32	9.4	9.4
Progesterone	21	9.2	9.2
Ceftriaxone	28	8.6	8.6
Remdesivir	11	8.2	8.3
Nifedipine	38	8.1	8.1
Ritonavir 100 Mg	12	8.0	8.0
Cefazolin	7	7.7	7.7
Oseltamivir Phosphate	18	7.4	7.4
Ceftriaxone Sodium	28	7.3	7.4
Rifampicin	7	6.9	6.9
Buprenorphine Hydrochloride, Naloxone Hydrochloride	15	6.2	6.2
Tenofovir Disoproxil Fumarate	20	6.1	6.1
Ifosfamide	12	5.6	5.6
Lamivudine Oral	14	5.5	5.5
Efavirenz	6	5.4	5.4
Levetiracetam In Sodium Chloride	39	5.1	5.1
Levetiracetam Oral	39	5.1	5.1
Levetiracetam Injection	39	5.1	5.1
Emtricitabine And Tenofovir Disoproxil Fumarate	23	5.1	5.1
Aripiprazole	60	5.0	5.0
Rocuronium Bromide	5	4.2	4.2
Eculizumab	22	4.1	4.1
Cabotegravir	3	3.7	3.7
Sevoflurane	3	3.6	3.6
Buprenorphine	29	3.1	3.1
Certolizumab Pegol	34	2.9	2.9
Peginterferon Beta-1A	3	2.3	2.3
Paliperidone Palmitate	7	2.2	2.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.